Le Lézard
Classified in: Covid-19 virus
Subject: ATY

BEYOND MEAT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Beyond Meat, Inc. - BYND


NEW ORLEANS, May 26, 2023 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 10, 2023 to file lead plaintiff applications in a securities class action lawsuit against  Beyond Meat, Inc. (NasdaqGS: BYND), if they purchased the Company's shares between May 5, 2020 and October 13, 2022, inclusive (the "Class Period").  This action is pending in the United States District Court for the Central District of California.

What You May Do

If you purchased shares of Beyond Meat and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-bynd/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 10, 2023.

About the Lawsuit

Beyond Meat and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

On November 10, 2021, post-market, the Company disclosed a $1.8 million inventory write-off, which it attributed to effects from Covid-19. On this news, shares of Beyond Meat fell $12.55 per share, or nearly 13%, to close at $81.93 per share on November 11, 2021.  Then, on December 9, 2021, media sources reported that Taco Bell had cancelled a planned test of Beyond Carne Asada due to ongoing quality concerns. On this news, shares of Beyond Meat fell $5.58 per share, or nearly 8%, to close at $64.51 per share on December 10, 2021. Finally, on October 14, 2022, pre-market, the Company disclosed the departure of its COO, CFO and CGO. On this news, shares of Beyond Meat fell $1.43 per share, or over 9.6%, to close at $13.35 per share on October 14, 2022.

The case is Retail Wholesale Department Store Union Local 338 Retirement Fund v. Beyond Meat, Inc., No. 23-cv-3602.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients ? including public institutional investors, hedge funds, money managers and retail investors ? in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you may visit http://ksfcounsel.com/.

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

SOURCE Kahn Swick & Foti, LLC


These press releases may also interest you

at 12:50
Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired QuidelOrtho Corporation ("QuidelOrtho"...

at 11:40
The "Global Needle Coke Market: Focus on Application, Type, Grade, End Use, and Country-Level Analysis - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The global needle coke market was valued at $3.05...

at 11:15
Expomed Eurasia, the most important medical exhibition between Europe and Asia, is ready to house more than a hundred companies, to discover new technological trends and the most innovative products which are going to change deeply the health market....

at 11:15
Nora Pharma, a Canadian pharmaceutical company, has received approval for its first Biosimilar product. Nora Pharma, a wholly owned division of Sunshine Biopharma, has received approval from Health Canada for the commercialization of NIOPEG® (a...

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...



News published on and distributed by: